Stock Analysis on Net

Boston Scientific Corp. (NYSE:BSX)

Selected Financial Data
since 2005

Beginner level

Income Statement
Balance Sheet: Assets
Balance Sheet: Liabilities and Stockholders’ Equity
Cash Flow Statement
Per Share Data

Income Statement

Boston Scientific Corp., selected items from income statement, long-term trends

US$ in millions

12 months ended:	Net sales	Operating income (loss)	Net income (loss)
Dec 31, 2019	10,735	1,518	4,700
Dec 31, 2018	9,823	1,506	1,671
Dec 31, 2017	9,048	1,285	104
Dec 31, 2016	8,386	447	347
Dec 31, 2015	7,477	(327)	(239)
Dec 31, 2014	7,380	(301)	(119)
Dec 31, 2013	7,143	120	(121)
Dec 31, 2012	7,249	(3,868)	(4,068)
Dec 31, 2011	7,622	904	441
Dec 31, 2010	7,806	(656)	(1,065)
Dec 31, 2009	8,188	(894)	(1,025)
Dec 31, 2008	8,050	(1,505)	(2,036)
Dec 31, 2007	8,357	(14)	(495)
Dec 31, 2006	7,821	(2,949)	(3,577)
Dec 31, 2005	6,283	968	628

Based on: 10-K (filing date: 2020-02-25), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-26), 10-K (filing date: 2013-02-22), 10-K (filing date: 2012-02-17), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-26), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-28), 10-K (filing date: 2007-03-01), 10-K (filing date: 2006-03-01).

Balance Sheet: Assets

Boston Scientific Corp., selected items from assets, long-term trends

US$ in millions

	Current assets	Total assets
Dec 31, 2019	4,699	30,565
Dec 31, 2018	4,003	20,999
Dec 31, 2017	3,822	19,042
Dec 31, 2016	3,239	18,096
Dec 31, 2015	3,471	18,133
Dec 31, 2014	3,606	17,042
Dec 31, 2013	3,011	16,571
Dec 31, 2012	3,022	17,154
Dec 31, 2011	3,105	21,290
Dec 31, 2010	3,615	22,128
Dec 31, 2009	4,061	25,177
Dec 31, 2008	5,452	27,139
Dec 31, 2007	5,921	31,197
Dec 31, 2006	4,901	31,096
Dec 31, 2005	2,631	8,196

Based on: 10-K (filing date: 2020-02-25), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-26), 10-K (filing date: 2013-02-22), 10-K (filing date: 2012-02-17), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-26), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-28), 10-K (filing date: 2007-03-01), 10-K (filing date: 2006-03-01).

Balance Sheet: Liabilities and Stockholders’ Equity

Boston Scientific Corp., selected items from liabilities and stockholders’ equity, long-term trends

US$ in millions

	Current liabilities	Total debt	Stockholders’ equity
Dec 31, 2019	4,866	10,008	13,877
Dec 31, 2018	5,260	7,056	8,726
Dec 31, 2017	5,654	5,616	7,012
Dec 31, 2016	3,587	5,484	6,733
Dec 31, 2015	2,430	5,677	6,320
Dec 31, 2014	2,846	4,262	6,457
Dec 31, 2013	1,824	4,240	6,539
Dec 31, 2012	1,772	4,256	6,870
Dec 31, 2011	1,807	4,261	11,353
Dec 31, 2010	2,609	5,438	11,296
Dec 31, 2009	3,022	5,918	12,301
Dec 31, 2008	3,233	6,745	13,174
Dec 31, 2007	3,250	8,189	15,097
Dec 31, 2006	2,630	9,124	15,298
Dec 31, 2005	1,479	2,020	4,282

Based on: 10-K (filing date: 2020-02-25), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-26), 10-K (filing date: 2013-02-22), 10-K (filing date: 2012-02-17), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-26), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-28), 10-K (filing date: 2007-03-01), 10-K (filing date: 2006-03-01).

Cash Flow Statement

Boston Scientific Corp., selected items from cash flow statement, long-term trends

US$ in millions

12 months ended:	Cash provided by operating activities	Cash (used for) provided by investing activities	Cash provided by (used for) financing activities
Dec 31, 2019	1,836	(5,041)	2,973
Dec 31, 2018	310	(1,921)	1,432
Dec 31, 2017	1,426	(1,010)	110
Dec 31, 2016	972	(887)	(206)
Dec 31, 2015	600	(2,186)	1,322
Dec 31, 2014	1,269	(745)	(150)
Dec 31, 2013	1,082	(475)	(596)
Dec 31, 2012	1,260	(579)	(744)
Dec 31, 2011	1,008	769	(1,721)
Dec 31, 2010	325	(480)	(496)
Dec 31, 2009	835	(793)	(820)
Dec 31, 2008	1,216	324	(1,350)
Dec 31, 2007	934	(474)	(680)
Dec 31, 2006	1,845	(9,312)	8,439
Dec 31, 2005	903	(551)	(954)

Based on: 10-K (filing date: 2020-02-25), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-26), 10-K (filing date: 2013-02-22), 10-K (filing date: 2012-02-17), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-26), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-28), 10-K (filing date: 2007-03-01), 10-K (filing date: 2006-03-01).

Boston Scientific Corp., selected data per share, long-term trends

US$

12 months ended:	Basic earnings per share ¹	Diluted earnings per share ²	Dividend per share ³
Dec 31, 2019	3.38	3.33	0.00
Dec 31, 2018	1.21	1.19	0.00
Dec 31, 2017	0.08	0.08	0.00
Dec 31, 2016	0.26	0.25	0.00
Dec 31, 2015	-0.18	-0.18	0.00
Dec 31, 2014	-0.09	-0.09	0.00
Dec 31, 2013	-0.09	-0.09	0.00
Dec 31, 2012	-2.89	-2.89	0.00
Dec 31, 2011	0.29	0.29	0.00
Dec 31, 2010	-0.70	-0.70	0.00
Dec 31, 2009	-0.68	-0.68	0.00
Dec 31, 2008	-1.36	-1.36	0.00
Dec 31, 2007	-0.33	-0.33	0.00
Dec 31, 2006	-2.81	-2.81	0.00
Dec 31, 2005	0.76	0.75	0.00

Based on: 10-K (filing date: 2020-02-25), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-26), 10-K (filing date: 2013-02-22), 10-K (filing date: 2012-02-17), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-26), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-28), 10-K (filing date: 2007-03-01), 10-K (filing date: 2006-03-01).

^{1, 2, 3} Data adjusted for splits and stock dividends.